Liver microwave ablation: a systematic review of various FDA-approved systems

Onderzoeksoutputpeer review

59 Citaten (Scopus)
437 Downloads (Pure)


ObjectivesThe aim of the present study is to analyze preclinical and clinical data on the performance of the currently US Food and Drug Administration (FDA)-approved microwave ablation (MWA) systems.MethodsA review of the literature, published between January 1, 2005, and December 31, 2016, on seven FDA-approved MWA systems, was conducted. Ratio of ablation zone volume to applied energy R(AZ:E) and sphericity indices were calculated for ex vivo and in vivo experiments.ResultsThirty-four studies with ex vivo, in vivo, and clinical data were summarized. In total, 14 studies reporting data on ablation zone volume and applied energy were included for comparison R(AZ:E). A significant correlation between volume and energy was found for the ex vivo experiments (r=0.85, p

Originele taal-2English
Pagina's (van-tot)4026-4035
Aantal pagina's10
TijdschriftEuropean Radiology
Nummer van het tijdschrift8
Vroegere onlinedatum30-nov.-2018
StatusPublished - aug.-2019

Citeer dit